1. Home
  2. DAWN vs MATW Comparison

DAWN vs MATW Comparison

Compare DAWN & MATW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Day One Biopharmaceuticals Inc.

DAWN

Day One Biopharmaceuticals Inc.

HOLD

Current Price

$12.12

Market Cap

908.7M

Sector

Health Care

ML Signal

HOLD

Logo Matthews International Corporation

MATW

Matthews International Corporation

HOLD

Current Price

$26.09

Market Cap

827.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAWN
MATW
Founded
2018
1850
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Metal Fabrications
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
908.7M
827.2M
IPO Year
2021
1994

Fundamental Metrics

Financial Performance
Metric
DAWN
MATW
Price
$12.12
$26.09
Analyst Decision
Strong Buy
Analyst Count
9
0
Target Price
$27.56
N/A
AVG Volume (30 Days)
2.5M
235.2K
Earning Date
02-24-2026
02-03-2026
Dividend Yield
N/A
3.73%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$133,672,000.00
$1,497,689,000.00
Revenue This Year
$17.32
N/A
Revenue Next Year
$53.42
$0.77
P/E Ratio
N/A
N/A
Revenue Growth
31.11
N/A
52 Week Low
$5.64
$18.50
52 Week High
$13.53
$31.94

Technical Indicators

Market Signals
Indicator
DAWN
MATW
Relative Strength Index (RSI) 67.13 45.53
Support Level $10.16 $27.24
Resistance Level $11.18 $29.11
Average True Range (ATR) 0.81 0.98
MACD 0.20 -0.10
Stochastic Oscillator 99.60 11.28

Price Performance

Historical Comparison
DAWN
MATW

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.

About MATW Matthews International Corporation

Matthews International Corp is a provider of memorialization products, industrial technologies and brand solutions. The company's segments are Memorialization, Industrial Technologies and Brand Solutions. The memorialization offerings include bronze and granite memorials, caskets, and cremation-related products and equipment for cemeteries and funeral homes. Its Industrial Technologies segment designs, manufactures, services, and sells custom energy storage systems and product identification and warehouse automation solutions. The Brand Solutions segment provides brand management, pre-media, printing plates and cylinders, imaging, digital asset management, merchandising displays, and marketing and design services. The majority of revenue is generated by Memorialization.

Share on Social Networks: